Complement receptor 1 (CD35) on human reticulocytes: Normal expression in systemic lupus erythematosus and HIV-infected patients

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7549-7554

  Lach Trifilieff, Estelle ^a   Marfurt, Jutta ^a   Schwarz, Sybille ^a   Sadallah, Salima ^a   Schifferli, Jürg A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUTOIMMUNITY; BLOOD TRANSFUSION; CELL LOSS; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETICULOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS EXPRESSION;

AGGLUTININS; AGING; ANEMIA, HEMOLYTIC, AUTOIMMUNE; CRYOGLOBULINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HIV INFECTIONS; HUMANS; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, COMPLEMENT 3B; RETICULOCYTES;

EID: 0033564907     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kazatchkine, M. D., and D. T. Fearon. 1990. Deficiencies of human complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). Immunodefic. Rev. 2:17.
2. Medof, M. E., K. Iida, C. Mold, and V. Nussenzweig. 1982. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J. Exp. Med. 156:1739.
3. Fearon, D. T. 1980. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med 152:20.
4. Nelson, R. A. 1953. The immune adherence phenomenon: an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science 118:733.
5. Schifferli, J. A., Y. C. Ng, and D. K. Peters. 1986. The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med 315:488.
6. Schifferli, J. A., Y. C. Ng, J. Estreicher, and M. J. Walport. 1988. The clearance of tetanus toxoid/antitetanus toxoid immune complexes from the circulation of humans. J. Immunol. 140:899.
7. Wilson, J. G., E. E. Murphy, W. W. Wong, L. B. Klickstein, J. H. Weis, and D. T. Fearon. 1986. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med. 164:50.
8. Moldenhauer, F., M. Botto, and M. J. Walport. 1988. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms. Clin. Exp. Immunol. 72:74.
9. Ripoche, J., and R. B. Sim. 1986. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes: studies of proteolytic release of the receptor Biochem. J. 235:815.
10. Pascual, M., C. Danielsson, G. Steiger, and J. A. Schifferli. 1994. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. Eur. J. Immunol. 24:702.
11. Taylor, R. P., F. Pocanic, C. Reist, and E. L. Wright. 1991. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes. Clin. Immunol. Immunopathol. 61:143.
12. Cohen, J. H., C. Geffriaud, V. Caudwell, and M. D. Kazatchkine. 1989. Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals. AIDS 3:397.
13. Iida, K., R. Momaghi, and V. Nussenzweig. 1982. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J. Exp. Med. 155:1427.
14. Jouvin, M. H., W. Rozenbaum, R. Russo, and M. D. Kazatchkine. 1987. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. AIDS 1:89.
15. Tausk, F., T. Hoffmann, R. Schreiber, and I. Gigli. 1985. Leprosy: altered complement receptors in disseminated disease. J. Invest. Dermatol. 85:585.
16. Tausk, F. A., A. McCutchan, P. Spechko, R. D. Schreiber, and I. Gigli. 1986. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J. Clin. Invest. 78:977.
17. Ross, G. D., W. J. Yount, M. J. Walport, J. B. Winfield, C. J. Parker, C. R. Fuller, R. P. Taylor, B. L. Myones, and P. J. Lachmann. 1985. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 135:2005.
18. Wilson, J. G., W. W. Wong, P. H. Schurr, and D. T. Fearon. 1982. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N. Engl. J. Med. 307:981.
19. Walport, M. J., G. D. Ross, C. Mackworth-Young, J. V. Watson, N. Hogg, and P. J. Lachmann, 1985. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin. Exp. Immunol. 59:547.
20. Kumar, A., A. Kumar, S. Sinha, P. S. Khandekar, K. Banerjee, and L. M. Srivastava. 1995. HindIII genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Immunol. Cell Biol. 73:457.
21. Cohen, J. H., H. U. Lutz, J. L. Pennaforte, A. Bouchard, and M. D. Kazatchkine. 1992. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 87:422.
22. Marquart, H. V., A. Svendsen, J. M. Rasmussen, C. H. Nielsen, P. Junker, S. E. Svehag, and R. G. Leslie. 1995. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 101:60.
23. Wilson, J. G., W. D. Ratnoff, P. H. Schur, and D. T. Fearon. 1986. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. 29:739.
24. Walport, M., Y. C. Ng, and P. J. Lachmann. 1987. Erythrocytes transfused into patients with SLE and hemolytic anemia lose complement receptor type 1 from their cell surface. Clin. Exp. Immunol. 69:501.
25. Barbosa, J. E., R. A. Harrison, P. J. Barker, and P. J. Lachmann. 1992. An anti-peptide antibody that recognizes a neo-antigen in the CR1 stump remaining on erythrocytes after proteolysis. Clin. Exp. Immunol. 87:144.
26. Cosio, F. G., X. P. Shen, D. J. Birmingham, M. Van Aman, and L. A. Hebert. 1990. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145:4198.
27. Davies, K. A., V. Hird, S. Stewart, G. B. Sivolapenko, P. Jose, A. A. Epenetos, and M. J. Walport. 1990. A study of in vivo immune complex formation and clearance in man. J. Immunol. 144:4613.
28. Brun, A., G. Gaudernack, and S. Sandberg. 1990. A new method for isolation of reticulocytes: positive selection of human reticulocytes by immunomagnetic separation. Blood 76:2397.
29. Ahn, J., and R. Johnstone. 1993. Origin of soluble truncated transferrin receptor. Blood 81:2442.
30. Pascual, M., M. A. Duchosal, G. Steiger, E. Giostra, A. Pechere, J. P. Paccaud, C. Danielsson, and J. A. Schifferli. 1993. Circulating soluble CR1 (CD35): serum levels in diseases and evidence for its release by human leukocytes. J. Immunol. 151:1702.
31. Nickells, M., R. Hauhart, M. Krych, V. B. Subramanian, K. Geoghegan-Barek, H. C. Marsh, Jr., and J. P. Atkinson. 1998. Mapping epitopes for 20 monoclonal antibodies to CR1. [Published erratum appears in 1998 Clin. Exp. Immunol. 113: 315] Clin. Exp. Immunol. 112:27.
32. Pascual, M., E. Catana, F. Spertini, K. Macon, J. E. Volanakis, and J. A. Schifferli. 1990. A monoclonal antibody which blocks the function of factor D of human complement. J. Immunol. Methods 127:263.
33. Vyse, T. J., P. J. Spath, K. A. Davies, B. J. Morley, P. Philippe, P. Athanassiou, C. M. Giles, and M. J. Walport. 1994. Hereditary complement factor I deficiency. Q. J. Med. 87:385.
34. Moulds, J. M., M. W. Nickells, J. J. Moulds, M. C. Brown, and J. P. Atkinson. 1991. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J. Exp. Med. 173:1159.
35. Rowe, J. A., J. M. Moulds, C. I. Newbold, and L. H. Miller. 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388:292.
36. Nielsen, C. H., J. M. Rasmussen, A. Voss, P. Junker, and R. G. Leslie. 1998. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes. Arthritis Rheum. 41:613.
37. Wilson, J. G., R. M. Jack, W. W. Wong, P. H. Schur, and D. T. Fearon. 1985. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus. J. Clin. Invest. 76:182.
38. Cook, J. M., M. D. Kazatchkine, P. Bourgeois, F. Mignon, J. P. Mery, and M. F. Kahn. 1986. Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 38:135.